Related references
Note: Only part of the references are listed.Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
Stefania Gorini et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Monoclonal antibodies in cancer immunotherapy
Ilgin Kimiz-Gebologlu et al.
MOLECULAR BIOLOGY REPORTS (2018)
Cancer Cell Membrane-Coated Gold Nanocages with Hyperthermia-Triggered Drug Release and Homotypic Target Inhibit Growth and Metastasis of Breast Cancer
Huiping Sun et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
Rational Design of Metal Organic Framework Nanocarrier-Based Codelivery System of Doxorubicin Hydrochloride/Verapamil Hydrochloride for Overcoming Multidrug Resistance with Efficient Targeted Cancer Therapy
Huiyuan Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials
Daiqin Chen et al.
ACS NANO (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Lactate Wreaks Havoc on Tumor-Infiltrating T and NK Cells
Kristen E. N. Scott et al.
Cell Metabolism (2016)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Wei Yang et al.
NATURE (2016)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
Daniel Sanghoon Shin et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
Damya Laoui et al.
CANCER RESEARCH (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
ACAT Inhibitors: The Search for Novel Cholesterol Lowering Agents
Palash Pal et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
Functional Interaction between Responses to Lactic Acidosis and Hypoxia Regulates Genomic Transcriptional Outputs
Xiaohu Tang et al.
CANCER RESEARCH (2012)
Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Melody A. Swartz et al.
CANCER RESEARCH (2012)
Cholesterol and Sphingomyelin Drive Ligand-independent T-cell Antigen Receptor Nanoclustering
Eszter Molnar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Tumor delivery of macromolecular drugs based on the EPR effect
Vladimir Torchilin
ADVANCED DRUG DELIVERY REVIEWS (2011)
Chiral Nanoporous Metal-Organic Frameworks with High Porosity as Materials for Drug Delivery
Chun-Yi Sun et al.
ADVANCED MATERIALS (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Acyl-coenzyme A: cholesterol acyltransferases
Ta-Yuan Chang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling
Tobias Zech et al.
EMBO JOURNAL (2009)
ACAT as a drug target for Alzheimer's disease
Henri J. Huttunen et al.
NEURODEGENERATIVE DISEASES (2008)
SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours
K Greish et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Metastatic breast cancer - Overview of treatment
SM Ali et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2003)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Share Paper
